Should I buy or sell Shockwave Medical stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 10 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SWAV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares. View SWAV analyst ratings or view top-rated stocks .

What is Shockwave Medical's stock price target for 2024?

11 Wall Street research analysts have issued twelve-month target prices for Shockwave Medical's shares. Their SWAV share price targets range from $210.00 to $368.00. On average, they predict the company's share price to reach $309.11 in the next twelve months. This suggests that the stock has a possible downside of 5.6%. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts .

How have SWAV shares performed in 2024?

Shockwave Medical's stock was trading at $190.56 at the beginning of 2024. Since then, SWAV stock has increased by 71.9% and is now trading at $327.50. View the best growth stocks for 2024 here .

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our SWAV earnings forecast .

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) announced its quarterly earnings data on Thursday, February, 15th. The company reported $1.16 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.24. The business earned $202.98 million during the quarter, compared to analysts' expectations of $199.43 million. Shockwave Medical had a trailing twelve-month return on equity of 23.97% and a net margin of 20.17%. The company's revenue was up 41.0% on a year-over-year basis. During the same period in the prior year, the firm posted $3.71 earnings per share.

What ETFs hold Shockwave Medical's stock?

ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS) , Motley Fool Small-Cap Growth ETF (TMFS) , MFAM Small-Cap Growth ETF (MFMS) , First Trust Indxx Medical Devices ETF (MDEV) , Motley Fool Mid-Cap Growth ETF (TMFM) , Motley Fool Global Opportunities ETF (TMFG) , Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and Alger Mid Cap 40 ETF (FRTY) .

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $910.0 million-$930.0 million, compared to the consensus revenue estimate of $918.9 million.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com . Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA) , Walt Disney (DIS) , Block (SQ) , Trade Desk (TTD) , Salesforce (CRM) , Roku (ROKU) , PayPal (PYPL) , DexCom (DXCM) , Alibaba Group (BABA) and Okta (OKTA) .

When did Shockwave Medical IPO?

Shockwave Medical (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Artemis Investment Management LLP (0.23%), APEIRON CAPITAL Ltd (0.02%), Los Angeles Capital Management LLC (0.02%), Wealth Management Partners LLC (0.01%), Wealth Enhancement Advisory Services LLC (0.01%) and Fermata Advisors LLC (0.01%). Insiders that own company stock include Antoine Papiernik , Colin Cahill , Dan Puckett , Douglas Evan Godshall , Frank T Watkins, Frank T Watkins , Frederic H Moll, Isaac Zacharias , Kurt F Gallo, Laura Francis , Maria Sainz , Sara Toyloy and Trinh Phung . View institutional ownership trends .

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Lowest-Rated StocksLowest-Rated

NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free SWAV Stock Alerts

$327.50

+0.40 (+0.12%)

(As of 05:33 PM ET)

Compare

Today's Range: $326.45
▼
$328.05
50-Day Range: $230.90
▼
$329.64
52-Week Range: $157.00
▼
$331.58

Volume: 1.25 million shs
Average Volume: 954,955 shs
Market Capitalization: $12.25 billion

P/E Ratio: 84.63
Dividend Yield: N/A
Price Target: $309.11

Get Shockwave Medical alerts:

Shockwave Medical MarketRank™ Stock Analysis

Analyst Rating: Hold
2.09 Rating Score
Upside/Downside: 5.6% Downside
$309.11 Price Target
Short Interest: Bearish
5.43% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.55
Upright™ Environmental Score
News Sentiment: 0.62
Based on 11 Articles This Week
Insider Trading: Selling Shares
$25.94 M Sold Last Quarter
Proj. Earnings Growth: 27.14%
From $4.90 to $6.23 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.20 out of 5 stars

Medical Sector

147th out of 930 stocks

Surgical & Medical Instruments Industry

24th out of 99 stocks

2.0

Analyst's Opinion

Consensus Rating
Shockwave Medical has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 1 buy rating, 10 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Shockwave Medical has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.0

Short Interest

Percentage of Shares Shorted
5.43% of the outstanding shares of Shockwave Medical have been sold short.
Short Interest Ratio / Days to Cover
Shockwave Medical has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Shockwave Medical has recently increased by 13.41%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Shockwave Medical does not currently pay a dividend.
Dividend Growth
Shockwave Medical does not have a long track record of dividend growth.

4.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Shockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for Shockwave Medical is -0.55.

2.6

News and Social Media Coverage

News Sentiment
Shockwave Medical has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 11 news articles for Shockwave Medical this week, compared to 7 articles on an average week.
Search Interest
Only 13 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -28% compared to the previous 30 days.
MarketBeat Follows
17 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 183% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $25,938,579.00 in company stock.
Percentage Held by Insiders
Only 3.40% of the stock of Shockwave Medical is held by insiders.
Percentage Held by Institutions
95.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Shockwave Medical are expected to grow by 27.14% in the coming year, from $4.90 to $6.23 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Shockwave Medical is 84.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.16.
Price to Earnings Ratio vs. Sector
The P/E ratio of Shockwave Medical is 84.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 212.86.
Price to Earnings Growth Ratio
Shockwave Medical has a PEG Ratio of 2.45. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Shockwave Medical has a P/B Ratio of 18.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Shockwave Medical Stock (NASDAQ:SWAV)

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SWAV Stock News Headlines

April 13, 2024 | marketbeat.com

MarketBeat Week in Review – 4/8 - 4/12 (SWAV)

The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation

April 8, 2024 | marketbeat.com

Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?

On April 5, 2024, Johnson & Johnson NYSE: JNJ announced its intent to acquire Shockwave Medical Inc. NASDAQ: SWAV for $13.1 billion. Under the terms of the proposed deal, JNJ will pay $335 per share, which is a 4.75% premium compared to Shockwave's closing price on April 4, 2024.

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 8, 2024 | marketbeat.com

Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs? (SWAV)

Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend

April 5, 2024 | marketbeat.com

Newmont, Shockwave Medical rise; John Bean fall, Friday, 4/4/2024

Stocks that are trading heavily or have substantial price changes on Friday: Newmont, Shockwave Medical rise; John Bean fall

March 28, 2024 | insidertrades.com

Laura Francis Sells 1,500 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) Stock

March 17, 2024 | insidertrades.com

Shockwave Medical, Inc. (NASDAQ:SWAV) Director Sells $507,300.00 in Stock

April 16, 2024 | finance.yahoo.com

J&J CFO on Q1 Earnings, Forecast and Product Pipeline

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 12, 2024 | finance.yahoo.com

Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

April 12, 2024 | finance.yahoo.com

Shockwave Medical (SWAV) Rose on Strong Financial Results

April 11, 2024 | benzinga.com

5 Things To Know In Investing This Week - The Shockwave Takeover Issue

April 9, 2024 | prnewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD

April 9, 2024 | prnewswire.com

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV

April 9, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Stock Rating Reaffirmed by SVB Leerink

April 9, 2024 | americanbankingnews.com

Shockwave Medical's (SWAV) Neutral Rating Reiterated at CL King

April 9, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Earns "Equal Weight" Rating from Morgan Stanley

April 9, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Receives Hold Rating from Deutsche Bank Aktiengesellschaft

April 8, 2024 | businesswire.com

SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV

April 8, 2024 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Shockwave Medical (SWAV)

April 8, 2024 | finance.yahoo.com

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

April 8, 2024 | globenewswire.com

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World' Study

April 7, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Sees Unusually-High Trading Volume

April 6, 2024 | msn.com

J&J Buys Shockwave Medical for $13.1B, Boosting Its Cardiovascular Treatment Portfolio

April 6, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Given "Hold" Rating at Needham & Company LLC

April 6, 2024 | americanbankingnews.com

Shockwave Medical's (SWAV) Hold Rating Reaffirmed at Canaccord Genuity Group

April 6, 2024 | americanbankingnews.com

Shockwave Medical (NASDAQ:SWAV) Receives "Peer Perform" Rating from Wolfe Research

See More Headlines

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/15/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:SWAV
CUSIP: N/A
CIK: 1642545
Web: www.shockwavemedical.com
Phone: (877) 775-4846
Fax: N/A
Employees: 1,468
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $309.11
High Stock Price Target: $368.00
Low Stock Price Target: $210.00
Potential Upside/Downside: -5.5%
Consensus Rating: Hold
Rating Score (0-4): 2.09
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.87
Trailing P/E Ratio: 84.52
Forward P/E Ratio: 66.76
P/E Growth: 2.45
Net Income: $147.28 million
Net Margins: 20.17%
Pretax Margin: 23.87%
Return on Equity: 23.97%
Return on Assets: 12.78%

Debt

Debt-to-Equity Ratio: 1.09
Current Ratio: 11.76
Quick Ratio: 10.73

Sales & Book Value

Annual Sales: $730.23 million
Price / Sales: 16.75
Cash Flow: $4.31 per share
Price / Cash Flow: 75.98
Book Value: $18.12 per share
Price / Book: 18.05

Miscellaneous

Outstanding Shares: 37,400,000
Free Float: 36,126,000
Market Cap: $12.23 billion
Optionable: Optionable
Beta: 0.92

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Douglas E. Godshall M.B.A. (Age 59)
President, CEO & Director
Comp: $1.57M
Mr. Isaac Zacharias (Age 49)
Chief Commercial Officer
Comp: $908.02k
Mr. Daniel Hawkins (Age 57)
Founder and Senior Advisor
Mr. John M. Adams (Age 77)
Co-Founder and Technical Advisor
Ms. Renee M. Gaeta (Age 42)
Chief Financial Officer
Mr. Luis Morales
Senior Vice President of Global Operations
Ms. Trinh Phung (Age 46)
Chief Accounting Officer, Principal Accounting Officer & VP of Finance
Ms. Debbie Kaster
Vice President of Investor Relations
Mr. Hajime Tada J.D.
General Counsel & Secretary
Mr. Robert Fletcher
Senior Vice President of Marketing & Market Access

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SWAV Stock Analysis - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 10 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SWAV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares.
View SWAV analyst ratings or view top-rated stocks.
What is Shockwave Medical's stock price target for 2024?: 11 Wall Street research analysts have issued twelve-month target prices for Shockwave Medical's shares. Their SWAV share price targets range from $210.00 to $368.00. On average, they predict the company's share price to reach $309.11 in the next twelve months. This suggests that the stock has a possible downside of 5.6%.
View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts.
How have SWAV shares performed in 2024?: Shockwave Medical's stock was trading at $190.56 at the beginning of 2024. Since then, SWAV stock has increased by 71.9% and is now trading at $327.50.
View the best growth stocks for 2024 here.
When is Shockwave Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our SWAV earnings forecast.
How were Shockwave Medical's earnings last quarter?: Shockwave Medical, Inc. (NASDAQ:SWAV) announced its quarterly earnings data on Thursday, February, 15th. The company reported $1.16 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.24. The business earned $202.98 million during the quarter, compared to analysts' expectations of $199.43 million. Shockwave Medical had a trailing twelve-month return on equity of 23.97% and a net margin of 20.17%. The company's revenue was up 41.0% on a year-over-year basis. During the same period in the prior year, the firm posted $3.71 earnings per share.
What ETFs hold Shockwave Medical's stock?: ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Motley Fool Small-Cap Growth ETF (TMFS), MFAM Small-Cap Growth ETF (MFMS), First Trust Indxx Medical Devices ETF (MDEV), Motley Fool Mid-Cap Growth ETF (TMFM), Motley Fool Global Opportunities ETF (TMFG), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and Alger Mid Cap 40 ETF (FRTY).

What guidance has Shockwave Medical issued on next quarter's earnings?: Shockwave Medical issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $910.0 million-$930.0 million, compared to the consensus revenue estimate of $918.9 million.
What is Doug Godshall's approval rating as Shockwave Medical's CEO?: 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.
What other stocks do shareholders of Shockwave Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).
When did Shockwave Medical IPO?: Shockwave Medical (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
Who are Shockwave Medical's major shareholders?: Shockwave Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Artemis Investment Management LLP (0.23%), APEIRON CAPITAL Ltd (0.02%), Los Angeles Capital Management LLC (0.02%), Wealth Management Partners LLC (0.01%), Wealth Enhancement Advisory Services LLC (0.01%) and Fermata Advisors LLC (0.01%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Frederic H Moll, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung.
View institutional ownership trends.
How do I buy shares of Shockwave Medical?: Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SWAV) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Shockwave Medical (SWAV) Stock Price, News & Analysis

Shockwave Medical MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Shockwave Medical Stock (NASDAQ:SWAV)

SWAV Stock Price History

SWAV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SWAV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™